Nplate OverviewRomiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production. Contents 1 Indications and Marketing 2 Treatment regimen 3 Clinical efficacy 4 Side-effects 5 External links 6 References Indications and Marketing The drug was developed by Amgen and is marketed under the trade name Nplate through a restricted usage program called NEXUS. During development and clinical trials the drug was called AMG531. Romiplostim...
Read more Nplate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Romiplostim
Recent Nplate Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 1mcg, 250mcg/0.5ml + 500mcg/1ml.
NDC Database Records for Nplate: (3 results)Sorted by National Drug Code
- 55513-221 Nplate 250 ug/.5ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amgen Inc
- 55513-222 Nplate 500 ug/ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amgen Inc
- 55513-223 Nplate 125 mg/.25ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amgen Inc
Other drugs which contain Romiplostim or a similar ingredient: (1 result)
Related Nplate Topics: